Breast cancer undergoing lumpectomy and with a pathologic complete response to neoadjuvant chemotherapy (ROSALIE) Some women with early-stage...
READ MORECNV-DNA methylation crosstalk and PWP2-mediated
by Mike Ecclestone | Jul 23, 2026 | Funded Projects
Translational reprogramming drive aggressive triple-negative breast cancer phenotypes in women of African ancestry Breast cancer does not...
READ MOREUp Close and Personal
by Mike Ecclestone | Feb 3, 2026 | News
Event Chair Nancy McMillan takes us behind the...
READ MORECornelia Schupp
by Mike Ecclestone | Dec 18, 2025 | Participant Profiles
“There is life after breast cancer, and I’m living it,” said Cornelia, our 2025 survivor spokesperson. “I want others to know that it’s going...
READ MORERe-purposing clinical sequencing data for broader breast cancer susceptibility profiling.
by Mike Ecclestone | Aug 9, 2025 | Funded Projects
Breast cancer is the second most common cause of cancer death among Canadian women. Most deaths occur because the cancer spreads to other parts...
READ MORE
Recent Comments